Dr. Michael E. Joseph, MD
Rheumatology (Rheumatology Physician)
- Medicare participating
At a glance
- Medical school
- University of Kansas School of Med (Kc/Wich/Sal) (1992)
- Years since graduation
- 34
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 1,158
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1992Medical school: University of Kansas School of Med (Kc/Wich/Sal)
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Rheumatology Physician primary
MO license 104718 -
Allergy & Immunology Physician
MO license 104718
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Mercy Hospital Joplin Joplin, MO
- Freeman Health System - Freeman West Joplin, MO
- Mercy Hospital Carthage Carthage, MO
- Freeman Neosho Hospital Neosho, MO
- Nevada Regional Medical Center Nevada, MO
Medical groups
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,158
- Services billed
- 450,717
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Injection, tocilizumab, 1 mg | 168,960 | 34 |
| Injection, golimumab, 1 mg, for intravenous use | 60,063 | 65 |
| Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 36,595 | 51 |
| Injection, denosumab, 1 mg | 21,902 | 231 |
| Injection, infliximab, excludes biosimilar, 10 mg | 21,470 | 69 |
| Injection, romosozumab-aqqg, 1 mg | 14,700 | 11 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 6,606 | 67 |
| Measurement of antibody for assessment of autoimmune disorder, any method | 4,802 | 421 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 4,781 | 1,034 |
| Red blood cell sedimentation rate, to detect inflammation, non-automated | 4,403 | 882 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Tramadol Hcl Other prescribers in Joplin, MO | 902 |
| Levothyroxine Sodium Other prescribers in Joplin, MO | 803 |
| Potassium Chloride Other prescribers in Joplin, MO | 600 |
| Methotrexate (methotrexate sodium) Other prescribers in Joplin, MO | 521 |
| Hydroxychloroquine Sulfate Other prescribers in Joplin, MO | 476 |
| Gabapentin Other prescribers in Joplin, MO | 432 |
| Amoxicillin-Clavulanate Potass (amoxicillin/potassium clav) Other prescribers in Joplin, MO | 421 |
| Celecoxib Other prescribers in Joplin, MO | 387 |
| Cefdinir Other prescribers in Joplin, MO | 383 |
| Pantoprazole Sodium Other prescribers in Joplin, MO | 339 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 10 companies reported 89 payments worth $1,352 in total to this clinician.
| Amgen Inc. | $431 |
|---|---|
| GlaxoSmithKline, LLC. | $318 |
| Pfizer Inc. | $206 |
| Novartis Pharmaceuticals Corporation | $132 |
| AbbVie Inc. | $78.43 |
| UCB, Inc. | $54.77 |
| AstraZeneca Pharmaceuticals LP | $43.79 |
| Ani Pharmaceuticals, Inc. | $35.01 |
| Food and Beverage | $1,352 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.